Anti-Osteoporosis Therapy and Fracture Healing Market is Expected to Witness a CAGR of 5.0% by 2026 | Detailed Analysis, Competitive Landscape with Novartis, Johnson and Johnson, GlaxoSmithKline PLC, Roche | FMI Report Review
Future Market Insights has recently published a report titled “Anti-Osteoporosis Therapy and Fracture Healing Market: Global Industry Analysis (2012 – 2017) and Opportunity Assessment (2018 – 2026).” The report states that despite the uncertainty in terms of political and economic scenario, the global healthcare industry is expected to receive a positive push from sectors such as medical imaging, in-vitro diagnostics, biotech and pharmaceuticals, and medical devices.
Key markets across the world are facing an enormous rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits. A speedily multiplying geriatric population, growing prevalence of chronic ailments such as cancer and cardiac disease, rising awareness among patients and high investments in clinical innovation are a few of the factors that are impacting the performance of the global healthcare industry at present. As a result of these factors, the global anti-osteoporosis therapy and fracture healing market is expected to witness a CAGR of 5.0% between 2018 and 2026.
Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1008
Growing Geriatric Population to Augur Adoption
Rising prevalence of osteoporosis is considered to be an important factor driving the global market, as the growing number of patients will also increase the demand for drugs and therapy. Furthermore, due to the absence of any substitutes such as surgery, demand for osteoporosis drugs is increasing constantly. According to the International Osteoporosis Foundation, almost 50% of the global bone fracture incidences would occur in the Asia Pacific region by 2050 end. A high occurrence and incidence rate of the disease is considered an important driver for the market. Furthermore, rising geriatric population is considered to be an important factor for the growth of the market in the coming years, although patent expiries of leading brands would considerably slow down the growth rate.
Bisphosphonates to Lead Among Drug Types
The global anti-osteoporosis therapy and fracture healing market has been segmented on the basis of drug type into bisphosphonates, calcitonin, estrogen or hormone replacement therapy, biologics, and anabolics. Among these, bisphosphonates is expected to emerge dominant by the end of 2026 with a valuation of around US$ 5,941 Mn in the same year.
Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1008
Preview Analysis on Anti-Osteoporosis Therapy and Fracture Healing Market Segmentation By Drug Type – Bisphosphonates, Calcitonin, Estrogen or Hormone Replacement Therapy, Biologics, Anabolics; By Route of Administration Type – Oral,Injectable; By Distribution Channel Type – Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce
Companies to Fight for Patent Rights
Leading companies in the market are competing against each other to gain patent rights on the different novel drugs that are being introduced in the market. This is further expected to intensify competition in the global market in the long run. Some of the companies operating in the global anti-osteoporosis therapy and fracture healing market are Novartis, Johnson and Johnson, GlaxoSmithKline PLC, Roche, Pfizer, MERCK, and AMGEN, among others.
Table Of Content
1. Global Anti-Osteoporosis Therapy and Fracture Healing Market – Executive Summary
2. Global Anti-Osteoporosis Therapy and Fracture Healing Market Overview
3. Global Anti-Osteoporosis Therapy and Fracture Healing Market Analysis and Forecast 2012-2026
4. North America Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026
5. Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026
Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1008
6. Europe Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026
7. Japan Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026
8. APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026
9. MEA Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026
10. Global Anti-Osteoporosis Therapy and Fracture Healing Market Company Share, Competition Landscape and Company Profiles
And So On…
Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape
Quadripodal Implants Market FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region.
Surgical Broaches Market Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region.
Surgical Rasps Market FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com